Vnitr Lek 2008, 54(10):979-984

Colorectal carcinoma and diabetes mellitus

V. Procházka*, R. Chlup
II. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Vlastimil Procházka, Ph.D.

The aim of this overview notification is to point out the risk factors and causes of colorectal carcinoma in diabetics. On the basis of recent information in the literature Type 2 diabetes mellitus has begun to appear as a potential risk factor for colorectal carcinoma. The work focuses on the link between them and outlines a possible solution to this topical issue. When tracking the diabetic population it is recommended that current depistage programmes for colorectal carcinoma be strictly maintained, that dispensing programmes not be neglected, in working with gastroenterologists to share the planning and specific preparation of a diabetic for endoscopy and other interventions and when treating with insulin to give preference to small complementary doses. It is proposed that the dispensing programme for this malignancy be modified for diabetics.

Keywords: diabetes mellitus; colorectal carcinoma; dispensing; depistage; epidemiology

Received: April 14, 2008; Accepted: June 9, 2008; Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Procházka V, Chlup R. Colorectal carcinoma and diabetes mellitus. Vnitr Lek. 2008;54(10):979-984.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bowker SL, Majumdar SR, Veugelers P et al. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonyllureas or insulin. Diabetes Care 2006; 29: 254-258. Go to original source... Go to PubMed...
    2. Cottet V, Pariente A, Nalet B et al. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology 2007; 133: 1086-1092. Go to original source... Go to PubMed...
    3. Ehrmann J Jr, Vavrušková N, Collan Y et al. Peorxisome proliferator-activated receptors (PPARs) in health and disease. Biomed Pap Med Fac Univ Palacky Olomouc 2002; 146: 11-14. Go to original source... Go to PubMed...
    4. Flood A, Mai V, Pfeiffer R et al. Elevated serum concentrations of insulin glucose increase risk of recurrent colorectal adenomas. Gastroenterology 2007; 133: 1423-1429. Go to original source... Go to PubMed...
    5. Frič P, Zavoral M, Seifert B et al. Screening sporadického kolorektálního karcinomu v ČR. Interní Med 2007; 5: 221-224.
    6. Huxley R, Ansary-Moghaddam A, Berrington GA et al. Type II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083. Go to original source... Go to PubMed...
    7. Chari ST, Leibon CL, Rabe KG et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008; 134: 344-345. Go to original source... Go to PubMed...
    8. Chung YW, Han DS, Park KH et al. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: A case-control study in Korea. Dis Colon Rectum 2008; 25, v tisku. Go to original source... Go to PubMed...
    9. Chung YW, Han DS, Park YK et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006; 38: 668-672. Go to original source... Go to PubMed...
    10. Jenab M, Riboli E, Cleveland RJ et al. Serum C-peptid, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 368-376. Go to original source... Go to PubMed...
    11. Kaaks R, Toniolo P, Akhmedkhanov A et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592-1600. Go to original source... Go to PubMed...
    12. Keku TO, Lund PK, Galanko J et al. Insulin resistence, apoptosis, and colorectal adenoma. Cancer Epidemiol Biomarkers Rev 2005; 14: 2076-2081. Go to original source... Go to PubMed...
    13. Larson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: J Natl Cancer Inst 2005; 97: 1679-1687. Go to original source... Go to PubMed...
    14. Ma J, Giovannucci E, Pollak M et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004; 96: 546-553. Go to original source... Go to PubMed...
    15. Nagel JM, Göke B. Colorectal carcinoma screening in patients with type 2 diabetes mellitus. J Gastroenterol 2006; 44: 1153-1165. Go to original source...
    16. Otani T, Iwasaki M, Sasazuki S et al. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Int J Cancer 2007; 120: 2007-2012. Go to original source... Go to PubMed...
    17. Saydah SH, Platz EA, Rifai N et al. Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 412-418.
    18. Schiel R, Müller UA, Braun A et al. Risk of malignancies in patients with insulin-tread diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN). Eur J Med Res 2005; 10: 339-344.
    19. Stevens RJ, Roddam AW, Beral V. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 2007; 96: 507-509. Go to original source... Go to PubMed...
    20. Svačina Š, Matoušek M. Diabetes a kolorektální karcinom. In: Perušičová J. Trendy soudobé diabetologie, svazek 7, 1. vyd. Praha: Galén 2003: 123-141.
    21. Svačina Š, Matoulek M, Svobodová Š et al. Nádory trávicího traktu a diabetes mellitus. Vnitř Lék 2004; 50: 386-391. Go to PubMed...
    22. Urban O. Zvláštnosti diagnostiky onemocnění trávicího ústrojí u diabetiků. Praktický lékař 2003; 83: 630-634.
    23. Ústav zdravotnických informací a statistiky ČR. Péče o nemocné cukrovkou 2006. In: Zdravotnická statistika. http://www.uzis.cz.
    24. Will JC, Galuska DA, Vinicor F et al. Colorectal cancer: another complication of diabetes mellitus? Amer J Epidemiol 1998; 147: 816-825. Go to original source... Go to PubMed...
    25. Winawer SJ, Zaber AG, Gerdes H et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334: 1339-1340. Go to original source...
    26. Yang YX, Hennessy S, Lewis JD. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004; 127: 1044-1050. Go to original source... Go to PubMed...
    27. Zavoral M, Frič P. Screening kolorektálního karcinomu. Interní Med 2007; 3: 149-150.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.